Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Bestqool Honors Workers With Light-Based Recovery Solutions This Labor Day 2025-08-27 23:31
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand 2025-08-27 23:09
Harbour BioMed Reports 2025 Interim Results 2025-08-27 22:40
XtalPi Holdings Announces 2025 Interim Results 2025-08-27 22:23
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0 2025-08-27 21:30
NUHS SPEARHEADS AI-POWERED BRAIN CARE PROGRAMME TO TACKLE UNDERDIAGNOSIS AND IMPROVE PREVENTION OF DEMENTIA 2025-08-27 21:00
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states 2025-08-27 20:00
Innovent Announces 2025 Interim Results and Business Updates 2025-08-27 18:08
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum 2025-08-27 14:02
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology 2025-08-26 21:00
Fosun Pharma Announces 2025 Interim Results 2025-08-26 20:42
Brightonix Imaging's High-Performance 'PHAROS' PET Receives FDA Clearance 2025-08-26 19:00
Peijia Medical Announces 2025 Interim Results 2025-08-25 20:00
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints 2025-08-25 13:46
Harbour BioMed Appoints Yajie Li as Chief Medical Officer 2025-08-25 09:00
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer 2025-08-25 08:00
WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES 2025-08-22 20:00
Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat 2025-08-22 13:22
Orange Biomed Lands on Fortune Korea's Top 40 with Portable Diabetes Test 2025-08-22 00:00
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization 2025-08-21 20:00